RG 6084
Alternative Names: PD-L1 LNA - Roche; RG-6084; RO-7191863Latest Information Update: 05 Jun 2025
At a glance
- Originator Roche
- Class Antisense oligonucleotides; Antivirals
- Mechanism of Action B7-H1 antigen expression inhibitors; Gene silencing
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 15 Nov 2024 Efficacy and adverse events data from a phase II trial in Hepatitis B presented at the 75th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD-2024)
- 15 Nov 2024 Safety, pharmacokinetics, efficacy and pharmacodynamics data from a phase I trial in Hepatitis Bpresented at the 75th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD-2024)
- 15 Nov 2024 Efficacy data from a phase II trial in Hepatitis B presented at the Liver Meeting 2024: 75th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD-2024)